Fda Predictions & Odds· 173 markets

F
FDA approves Outlook Therapeutics' ONS-5010?

Yes

$7k Vol.
$0 Liq.
Ended
F
FDA approves Viatris' low-dose estrogen weekly patch?

Yes

$5k Vol.
$0 Liq.
Ended
F
FDA approves MannKind's FUROSCIX ReadyFlow Autoinjector?

Yes

$778 Vol.
$0 Liq.
Ended
F
FDA approves Corcept Therapeutics' Relacorilant?

Yes

$4k Vol.
$0 Liq.
Ended
F
FDA approves Otsuka's Centanafadine?

Yes

$982 Vol.
$0 Liq.
Ended
F
FDA approves Sanofi's Subcutaneous Sarclisa?

Yes

$9k Vol.
$0 Liq.
Ended
F
FDA approves Celcuity's Gedatolisib?

Yes

$320 Vol.
$0 Liq.
Ended
F
FDA approves Vera Therapeutics' Atacicept?

Yes

$657 Vol.
$0 Liq.
Ended
F
FDA approves Daiichi Sankyo & AstraZeneca's Enhertu?

Yes

$907 Vol.
$0 Liq.
Ended
F
FDA approves Viridian Therapeutics' Veligrotug?

Yes

$15k Vol.
$0 Liq.
Ended